nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ABCB1—kidney cancer	0.139	1	CbGaD
Olanzapine—ORM1—Erlotinib—kidney cancer	0.0649	0.0955	CbGbCtD
Olanzapine—HTR2B—Sorafenib—kidney cancer	0.056	0.0825	CbGbCtD
Olanzapine—ABCB1—Temsirolimus—kidney cancer	0.0381	0.0561	CbGbCtD
Olanzapine—HTR2C—Sorafenib—kidney cancer	0.0365	0.0537	CbGbCtD
Olanzapine—CYP2D6—Temsirolimus—kidney cancer	0.0359	0.0528	CbGbCtD
Olanzapine—CYP3A4—Everolimus—kidney cancer	0.0338	0.0497	CbGbCtD
Olanzapine—ALB—Erlotinib—kidney cancer	0.0273	0.0402	CbGbCtD
Olanzapine—CYP1A2—Pazopanib—kidney cancer	0.0229	0.0337	CbGbCtD
Olanzapine—CYP3A4—Temsirolimus—kidney cancer	0.0228	0.0336	CbGbCtD
Olanzapine—CYP2C9—Capecitabine—kidney cancer	0.0215	0.0316	CbGbCtD
Olanzapine—ABCB1—Pazopanib—kidney cancer	0.02	0.0294	CbGbCtD
Olanzapine—CYP2D6—Pazopanib—kidney cancer	0.0188	0.0277	CbGbCtD
Olanzapine—ABCB1—Dactinomycin—kidney cancer	0.0183	0.0269	CbGbCtD
Olanzapine—CYP1A2—Erlotinib—kidney cancer	0.0163	0.024	CbGbCtD
Olanzapine—ABCB1—Gemcitabine—kidney cancer	0.0145	0.0213	CbGbCtD
Olanzapine—CYP2C19—Sorafenib—kidney cancer	0.0144	0.0212	CbGbCtD
Olanzapine—ABCB1—Erlotinib—kidney cancer	0.0143	0.021	CbGbCtD
Olanzapine—CYP2C9—Paclitaxel—kidney cancer	0.0135	0.0198	CbGbCtD
Olanzapine—CYP2D6—Erlotinib—kidney cancer	0.0134	0.0198	CbGbCtD
Olanzapine—CYP1A2—Sorafenib—kidney cancer	0.0133	0.0195	CbGbCtD
Olanzapine—ABCB1—Paclitaxel—kidney cancer	0.0131	0.0192	CbGbCtD
Olanzapine—CYP3A4—Pazopanib—kidney cancer	0.012	0.0176	CbGbCtD
Olanzapine—CYP2C9—Sorafenib—kidney cancer	0.012	0.0176	CbGbCtD
Olanzapine—ABCB1—Sorafenib—kidney cancer	0.0116	0.0171	CbGbCtD
Olanzapine—ABCB1—Vinblastine—kidney cancer	0.0115	0.0169	CbGbCtD
Olanzapine—ABCB1—Vincristine—kidney cancer	0.0113	0.0166	CbGbCtD
Olanzapine—CHRM3—ureter—kidney cancer	0.0111	0.172	CbGeAlD
Olanzapine—CYP2D6—Sorafenib—kidney cancer	0.0109	0.0161	CbGbCtD
Olanzapine—CYP2D6—Vinblastine—kidney cancer	0.0108	0.0159	CbGbCtD
Olanzapine—ABCB1—Sunitinib—kidney cancer	0.0094	0.0138	CbGbCtD
Olanzapine—CYP3A4—Erlotinib—kidney cancer	0.00855	0.0126	CbGbCtD
Olanzapine—CYP3A4—Paclitaxel—kidney cancer	0.00783	0.0115	CbGbCtD
Olanzapine—FMO3—urine—kidney cancer	0.00758	0.117	CbGeAlD
Olanzapine—ABCB1—Doxorubicin—kidney cancer	0.00704	0.0104	CbGbCtD
Olanzapine—CYP3A4—Sorafenib—kidney cancer	0.00695	0.0102	CbGbCtD
Olanzapine—CYP3A4—Vinblastine—kidney cancer	0.00687	0.0101	CbGbCtD
Olanzapine—CYP3A4—Vincristine—kidney cancer	0.00675	0.00994	CbGbCtD
Olanzapine—CYP2D6—Doxorubicin—kidney cancer	0.00663	0.00977	CbGbCtD
Olanzapine—CYP3A4—Sunitinib—kidney cancer	0.00563	0.00829	CbGbCtD
Olanzapine—CYP3A4—Doxorubicin—kidney cancer	0.00422	0.00621	CbGbCtD
Olanzapine—CYP2C19—urine—kidney cancer	0.00335	0.0519	CbGeAlD
Olanzapine—CYP1A2—urine—kidney cancer	0.00273	0.0424	CbGeAlD
Olanzapine—CYP2C9—urine—kidney cancer	0.0026	0.0402	CbGeAlD
Olanzapine—HTR2A—urine—kidney cancer	0.00214	0.0331	CbGeAlD
Olanzapine—CYP3A4—urine—kidney cancer	0.00198	0.0307	CbGeAlD
Olanzapine—CYP2D6—urine—kidney cancer	0.00195	0.0302	CbGeAlD
Olanzapine—H1F0—nephron tubule—kidney cancer	0.0015	0.0232	CbGeAlD
Olanzapine—HRH2—cardiac atrium—kidney cancer	0.00148	0.0229	CbGeAlD
Olanzapine—ADRA1B—renal system—kidney cancer	0.00144	0.0223	CbGeAlD
Olanzapine—ADRA1B—kidney—kidney cancer	0.00139	0.0216	CbGeAlD
Olanzapine—H1F0—renal system—kidney cancer	0.00136	0.0211	CbGeAlD
Olanzapine—H1F0—kidney—kidney cancer	0.00131	0.0204	CbGeAlD
Olanzapine—H1F0—cortex of kidney—kidney cancer	0.00128	0.0198	CbGeAlD
Olanzapine—H1F0—gonad—kidney cancer	0.00122	0.0189	CbGeAlD
Olanzapine—H1F0—cardiac atrium—kidney cancer	0.00122	0.0189	CbGeAlD
Olanzapine—HTR1D—kidney—kidney cancer	0.00102	0.0158	CbGeAlD
Olanzapine—HTR2B—cortex of kidney—kidney cancer	0.000922	0.0143	CbGeAlD
Olanzapine—CHRM3—renal system—kidney cancer	0.000881	0.0137	CbGeAlD
Olanzapine—HTR1A—renal system—kidney cancer	0.000878	0.0136	CbGeAlD
Olanzapine—CHRM3—kidney—kidney cancer	0.000852	0.0132	CbGeAlD
Olanzapine—ADRA2C—nephron tubule—kidney cancer	0.000848	0.0131	CbGeAlD
Olanzapine—HTR7—renal system—kidney cancer	0.000839	0.013	CbGeAlD
Olanzapine—HTR7—kidney—kidney cancer	0.000811	0.0126	CbGeAlD
Olanzapine—ADRA1A—renal system—kidney cancer	0.000809	0.0125	CbGeAlD
Olanzapine—ADRA2C—renal system—kidney cancer	0.000771	0.0119	CbGeAlD
Olanzapine—HTR7—gonad—kidney cancer	0.000752	0.0117	CbGeAlD
Olanzapine—ADRA2C—kidney—kidney cancer	0.000745	0.0115	CbGeAlD
Olanzapine—ADRA2C—cortex of kidney—kidney cancer	0.000726	0.0112	CbGeAlD
Olanzapine—ADRA2C—cardiac atrium—kidney cancer	0.00069	0.0107	CbGeAlD
Olanzapine—CYP1A2—renal system—kidney cancer	0.000669	0.0104	CbGeAlD
Olanzapine—ADRA2A—cortex of kidney—kidney cancer	0.000579	0.00897	CbGeAlD
Olanzapine—ADRA2A—gonad—kidney cancer	0.000552	0.00855	CbGeAlD
Olanzapine—ADRA2A—cardiac atrium—kidney cancer	0.000551	0.00853	CbGeAlD
Olanzapine—HTR2A—renal system—kidney cancer	0.000523	0.0081	CbGeAlD
Olanzapine—HTR2A—kidney—kidney cancer	0.000506	0.00783	CbGeAlD
Olanzapine—CYP3A4—renal system—kidney cancer	0.000484	0.0075	CbGeAlD
Olanzapine—CYP2D6—renal system—kidney cancer	0.000476	0.00738	CbGeAlD
Olanzapine—HTR2A—gonad—kidney cancer	0.000469	0.00727	CbGeAlD
Olanzapine—CYP3A4—kidney—kidney cancer	0.000468	0.00725	CbGeAlD
Olanzapine—CYP2D6—kidney—kidney cancer	0.000461	0.00714	CbGeAlD
Olanzapine—ABCB1—nephron tubule—kidney cancer	0.000377	0.00584	CbGeAlD
Olanzapine—ABCB1—renal system—kidney cancer	0.000343	0.00531	CbGeAlD
Olanzapine—ABCB1—kidney—kidney cancer	0.000331	0.00513	CbGeAlD
Olanzapine—ABCB1—cortex of kidney—kidney cancer	0.000323	0.005	CbGeAlD
Olanzapine—ABCB1—gonad—kidney cancer	0.000307	0.00476	CbGeAlD
Olanzapine—CHRM3—Signaling Pathways—RAF1—kidney cancer	4.44e-06	3.8e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MYC—kidney cancer	4.43e-06	3.8e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—RELA—kidney cancer	4.43e-06	3.8e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	4.43e-06	3.79e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	4.43e-06	3.79e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL2—kidney cancer	4.43e-06	3.79e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—ERBB2—kidney cancer	4.42e-06	3.79e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—RELA—kidney cancer	4.42e-06	3.78e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	4.42e-06	3.78e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—KRAS—kidney cancer	4.41e-06	3.77e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—ERBB2—kidney cancer	4.41e-06	3.77e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—RAF1—kidney cancer	4.4e-06	3.76e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—ERBB2—kidney cancer	4.39e-06	3.76e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	4.38e-06	3.75e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MAPK1—kidney cancer	4.38e-06	3.75e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CCND1—kidney cancer	4.38e-06	3.75e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—RELA—kidney cancer	4.38e-06	3.75e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.37e-06	3.75e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—JUN—kidney cancer	4.37e-06	3.75e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PTEN—kidney cancer	4.37e-06	3.74e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MTOR—kidney cancer	4.37e-06	3.74e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—RELA—kidney cancer	4.37e-06	3.74e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MTOR—kidney cancer	4.36e-06	3.74e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PTEN—kidney cancer	4.35e-06	3.73e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	4.35e-06	3.72e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MTOR—kidney cancer	4.35e-06	3.72e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MAPK3—kidney cancer	4.34e-06	3.72e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	4.34e-06	3.72e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MAPK1—kidney cancer	4.34e-06	3.72e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	4.34e-06	3.71e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—KRAS—kidney cancer	4.34e-06	3.71e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MTOR—kidney cancer	4.33e-06	3.71e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CCND1—kidney cancer	4.31e-06	3.69e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—JUN—kidney cancer	4.31e-06	3.69e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MTOR—kidney cancer	4.29e-06	3.68e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MAPK3—kidney cancer	4.29e-06	3.67e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	4.28e-06	3.67e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—KRAS—kidney cancer	4.28e-06	3.66e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	4.27e-06	3.66e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PTEN—kidney cancer	4.23e-06	3.62e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MYC—kidney cancer	4.23e-06	3.62e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.21e-06	3.6e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—POMC—kidney cancer	4.19e-06	3.58e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	4.17e-06	3.57e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MYC—kidney cancer	4.17e-06	3.57e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—PIK3CA—kidney cancer	4.17e-06	3.57e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PTEN—kidney cancer	4.16e-06	3.57e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—PIK3CA—kidney cancer	4.16e-06	3.56e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—KRAS—kidney cancer	4.14e-06	3.55e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	4.14e-06	3.54e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MAPK1—kidney cancer	4.13e-06	3.54e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PTEN—kidney cancer	4.11e-06	3.52e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	4.1e-06	3.51e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	4.1e-06	3.51e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—KRAS—kidney cancer	4.1e-06	3.51e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	4.09e-06	3.51e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	4.09e-06	3.5e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—POMC—kidney cancer	4.09e-06	3.5e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	4.08e-06	3.49e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL2—kidney cancer	4.08e-06	3.49e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MAPK1—kidney cancer	4.08e-06	3.49e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	4.07e-06	3.49e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	4.07e-06	3.48e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—RELA—kidney cancer	4.06e-06	3.47e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	4.05e-06	3.47e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—kidney cancer	4.03e-06	3.45e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	4.03e-06	3.45e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	4.03e-06	3.45e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—kidney cancer	4.03e-06	3.45e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	4.02e-06	3.44e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL2—kidney cancer	4.01e-06	3.44e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL2—kidney cancer	4.01e-06	3.43e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—kidney cancer	4e-06	3.43e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL2—kidney cancer	3.99e-06	3.42e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—PIK3CA—kidney cancer	3.98e-06	3.41e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL2—kidney cancer	3.98e-06	3.41e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CCND1—kidney cancer	3.98e-06	3.41e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	3.98e-06	3.41e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—JUN—kidney cancer	3.97e-06	3.4e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	3.95e-06	3.38e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL2—kidney cancer	3.94e-06	3.38e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	3.94e-06	3.37e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL2—kidney cancer	3.93e-06	3.37e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	3.93e-06	3.37e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	3.93e-06	3.36e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—kidney cancer	3.92e-06	3.35e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CCND1—kidney cancer	3.91e-06	3.35e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—JUN—kidney cancer	3.91e-06	3.34e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CCND1—kidney cancer	3.91e-06	3.34e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—KRAS—kidney cancer	3.9e-06	3.34e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—JUN—kidney cancer	3.9e-06	3.34e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CCND1—kidney cancer	3.89e-06	3.33e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—JUN—kidney cancer	3.88e-06	3.33e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CCND1—kidney cancer	3.88e-06	3.32e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	3.88e-06	3.32e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.88e-06	3.32e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—JUN—kidney cancer	3.87e-06	3.32e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	3.87e-06	3.31e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	3.87e-06	3.31e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	3.86e-06	3.3e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—kidney cancer	3.86e-06	3.3e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—KRAS—kidney cancer	3.85e-06	3.3e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—POMC—kidney cancer	3.85e-06	3.3e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CCND1—kidney cancer	3.84e-06	3.29e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	3.84e-06	3.29e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PTEN—kidney cancer	3.84e-06	3.29e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—JUN—kidney cancer	3.83e-06	3.28e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	3.83e-06	3.28e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—JUN—kidney cancer	3.82e-06	3.27e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	3.82e-06	3.27e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—POMC—kidney cancer	3.82e-06	3.27e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	3.81e-06	3.26e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	3.8e-06	3.26e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—kidney cancer	3.8e-06	3.26e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	3.8e-06	3.25e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PTEN—kidney cancer	3.78e-06	3.23e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PTEN—kidney cancer	3.77e-06	3.23e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	3.76e-06	3.22e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MYC—kidney cancer	3.76e-06	3.22e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	3.76e-06	3.22e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PTEN—kidney cancer	3.76e-06	3.22e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PTEN—kidney cancer	3.75e-06	3.21e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	3.74e-06	3.2e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	3.73e-06	3.2e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—kidney cancer	3.72e-06	3.19e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	3.72e-06	3.18e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PTEN—kidney cancer	3.71e-06	3.18e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	3.7e-06	3.17e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	3.68e-06	3.15e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—kidney cancer	3.68e-06	3.15e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.67e-06	3.14e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2—kidney cancer	3.65e-06	3.13e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—kidney cancer	3.64e-06	3.12e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—kidney cancer	3.63e-06	3.11e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	3.62e-06	3.1e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—kidney cancer	3.62e-06	3.1e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.59e-06	3.08e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PIK3CA—kidney cancer	3.59e-06	3.07e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PIK3CA—kidney cancer	3.57e-06	3.06e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.56e-06	3.05e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	3.56e-06	3.05e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	3.56e-06	3.05e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	3.56e-06	3.04e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.55e-06	3.04e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PIK3CA—kidney cancer	3.54e-06	3.03e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	3.54e-06	3.03e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.53e-06	3.02e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—kidney cancer	3.52e-06	3.01e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KRAS—kidney cancer	3.48e-06	2.98e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—kidney cancer	3.47e-06	2.97e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—kidney cancer	3.47e-06	2.97e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—kidney cancer	3.46e-06	2.96e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	3.44e-06	2.95e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.44e-06	2.94e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—kidney cancer	3.42e-06	2.93e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	3.41e-06	2.92e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—kidney cancer	3.4e-06	2.92e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	3.39e-06	2.91e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	3.39e-06	2.9e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—kidney cancer	3.38e-06	2.9e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.38e-06	2.89e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KRAS—kidney cancer	3.36e-06	2.88e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	3.35e-06	2.87e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.34e-06	2.86e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KRAS—kidney cancer	3.34e-06	2.86e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—kidney cancer	3.34e-06	2.86e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK3—kidney cancer	3.28e-06	2.81e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—POMC—kidney cancer	3.26e-06	2.79e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—kidney cancer	3.26e-06	2.79e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KRAS—kidney cancer	3.25e-06	2.78e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTEN—kidney cancer	3.24e-06	2.78e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.23e-06	2.76e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK3—kidney cancer	3.22e-06	2.76e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	3.21e-06	2.75e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK3—kidney cancer	3.2e-06	2.74e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	3.2e-06	2.74e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	3.2e-06	2.74e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—kidney cancer	3.19e-06	2.73e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	3.17e-06	2.71e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	3.16e-06	2.71e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PIK3CA—kidney cancer	3.16e-06	2.71e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—kidney cancer	3.14e-06	2.69e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—kidney cancer	3.13e-06	2.68e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—kidney cancer	3.12e-06	2.67e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK1—kidney cancer	3.12e-06	2.67e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—kidney cancer	3.11e-06	2.67e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	3.1e-06	2.66e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—kidney cancer	3.09e-06	2.65e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	3.08e-06	2.64e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—kidney cancer	3.08e-06	2.64e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—kidney cancer	3.07e-06	2.63e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	3.07e-06	2.63e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.07e-06	2.63e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	3.07e-06	2.63e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK1—kidney cancer	3.06e-06	2.62e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	3.05e-06	2.62e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK1—kidney cancer	3.05e-06	2.61e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—kidney cancer	3.04e-06	2.61e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	3.02e-06	2.58e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	3.01e-06	2.58e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	2.99e-06	2.56e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—kidney cancer	2.98e-06	2.56e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—kidney cancer	2.97e-06	2.54e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KRAS—kidney cancer	2.95e-06	2.52e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	2.94e-06	2.52e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	2.94e-06	2.51e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTEN—kidney cancer	2.91e-06	2.49e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KRAS—kidney cancer	2.9e-06	2.48e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.9e-06	2.48e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KRAS—kidney cancer	2.89e-06	2.48e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.89e-06	2.47e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KRAS—kidney cancer	2.89e-06	2.47e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KRAS—kidney cancer	2.88e-06	2.46e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.86e-06	2.45e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KRAS—kidney cancer	2.85e-06	2.44e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTEN—kidney cancer	2.84e-06	2.43e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—kidney cancer	2.84e-06	2.43e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.84e-06	2.43e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.79e-06	2.39e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.71e-06	2.32e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTEN—kidney cancer	2.68e-06	2.29e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	2.67e-06	2.28e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	2.66e-06	2.28e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTEN—kidney cancer	2.66e-06	2.27e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	2.65e-06	2.27e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	2.64e-06	2.26e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.64e-06	2.26e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—kidney cancer	2.62e-06	2.24e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	2.62e-06	2.24e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.61e-06	2.23e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—kidney cancer	2.6e-06	2.23e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—kidney cancer	2.58e-06	2.21e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—kidney cancer	2.57e-06	2.2e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—kidney cancer	2.56e-06	2.2e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—kidney cancer	2.56e-06	2.19e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—kidney cancer	2.53e-06	2.17e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.52e-06	2.16e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—POMC—kidney cancer	2.52e-06	2.16e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.42e-06	2.08e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.35e-06	2.01e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CA—kidney cancer	2.29e-06	1.96e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTEN—kidney cancer	2.27e-06	1.94e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.05e-06	1.76e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.01e-06	1.72e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CA—kidney cancer	2.01e-06	1.72e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.89e-06	1.62e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.87e-06	1.6e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTEN—kidney cancer	1.75e-06	1.5e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.6e-06	1.37e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.24e-06	1.06e-05	CbGpPWpGaD
